These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 1537131)

  • 1. Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty.
    Bairati I; Roy L; Meyer F
    Circulation; 1992 Mar; 85(3):950-6. PubMed ID: 1537131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized, and double-blind trial on the effect of fish oil on the incidence of restenosis following PTCA.
    Franzen D; Schannwell M; Oette K; Höpp HW
    Cathet Cardiovasc Diagn; 1993 Apr; 28(4):301-10. PubMed ID: 8462079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish oil supplements for prevention of restenosis after coronary angioplasty.
    Kaul U; Sanghvi S; Bahl VK; Dev V; Wasir HS
    Int J Cardiol; 1992 Apr; 35(1):87-93. PubMed ID: 1563884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do fish oils prevent restenosis after coronary angioplasty?
    Leaf A; Jorgensen MB; Jacobs AK; Cote G; Schoenfeld DA; Scheer J; Weiner BH; Slack JD; Kellett MA; Raizner AE
    Circulation; 1994 Nov; 90(5):2248-57. PubMed ID: 7955181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of postcoronary angioplasty restenosis by omega-3 fatty acids: main results of the Esapent for Prevention of Restenosis ITalian Study (ESPRIT).
    Maresta A; Balduccelli M; Varani E; Marzilli M; Galli C; Heiman F; Lavezzari M; Stragliotto E; De Caterina R;
    Am Heart J; 2002 Jun; 143(6):E5. PubMed ID: 12075272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty.
    Grigg LE; Kay TW; Valentine PA; Larkins R; Flower DJ; Manolas EG; O'Dea K; Sinclair AJ; Hopper JL; Hunt D
    J Am Coll Cardiol; 1989 Mar; 13(3):665-72. PubMed ID: 2537349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised trial of fish oil for prevention of restenosis after coronary angioplasty.
    Reis GJ; Boucher TM; Sipperly ME; Silverman DI; McCabe CH; Baim DS; Sacks FM; Grossman W; Pasternak RC
    Lancet; 1989 Jul; 2(8656):177-81. PubMed ID: 2568519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of fish oil supplements in preventing clinical evidence of restenosis after percutaneous transluminal coronary angioplasty.
    Milner MR; Gallino RA; Leffingwell A; Pichard AD; Brooks-Robinson S; Rosenberg J; Little T; Lindsay J
    Am J Cardiol; 1989 Aug; 64(5):294-9. PubMed ID: 2526993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial.
    Johansen O; Brekke M; Seljeflot I; Abdelnoor M; Arnesen H
    J Am Coll Cardiol; 1999 May; 33(6):1619-26. PubMed ID: 10334433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study.
    Cairns JA; Gill J; Morton B; Roberts R; Gent M; Hirsh J; Holder D; Finnie K; Marquis JF; Naqvi S; Cohen E
    Circulation; 1996 Oct; 94(7):1553-60. PubMed ID: 8840843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.
    Yokoi H; Daida H; Kuwabara Y; Nishikawa H; Takatsu F; Tomihara H; Nakata Y; Kutsumi Y; Ohshima S; Nishiyama S; Seki A; Kato K; Nishimura S; Kanoh T; Yamaguchi H
    J Am Coll Cardiol; 1997 Oct; 30(4):855-62. PubMed ID: 9316509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled Evaluation.
    Karsch KR; Preisack MB; Baildon R; Eschenfelder V; Foley D; Garcia EJ; Kaltenbach M; Meisner C; Selbmann HK; Serruys PW; Shiu MF; Sujatta M; Bonan R
    J Am Coll Cardiol; 1996 Nov; 28(6):1437-43. PubMed ID: 8917255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPA in the prevention of restenosis post PTCA.
    Bowles MH; Klonis D; Plavac TG; Gonzales B; Francisco DA; Roberts RW; Boxberger GR; Poliner LR; Galichia JP
    Angiology; 1991 Mar; 42(3):187-94. PubMed ID: 2018239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
    Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
    Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis.
    Gapinski JP; VanRuiswyk JV; Heudebert GR; Schectman GS
    Arch Intern Med; 1993 Jul; 153(13):1595-601. PubMed ID: 8323422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Circulation; 1992 Jul; 86(1):100-10. PubMed ID: 1535568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study.
    Aslan A; Triadafilopoulos G
    Am J Gastroenterol; 1992 Apr; 87(4):432-7. PubMed ID: 1553930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial.
    Serruys PW; Klein W; Tijssen JP; Rutsch W; Heyndrickx GR; Emanuelsson H; Ball SG; Decoster O; Schroeder E; Liberman H
    Circulation; 1993 Oct; 88(4 Pt 1):1588-601. PubMed ID: 8403306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site. A quantitative angiographic study in consecutive patients undergoing a third angioplasty procedure for a second restenosis.
    Bauters C; Mc Fadden EP; Lablanche JM; Quandalle P; Bertrand ME
    Circulation; 1993 Sep; 88(3):969-74. PubMed ID: 8353924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.